Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
14.66
+0.24 (1.66%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Biohaven Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-654.25-745.38-885.11-436.05-567.93-218.9
Net Income
-647.68-738.82-846.42-408.17-570.28-213.8
Earnings Per Share
-5.67-6.86-9.28-5.73-12.75-5.43
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
347.82319.14485.99381.82465.3476.06
Total Debt
280.28278.8632.7827.5730.582.8
Net Cash (Debt)
67.5440.28453.21354.25434.7673.26
Net Cash Growth
-76.87%-91.11%27.93%-18.52%493.45%-11.21%
Net Cash Per Share
0.570.374.974.989.721.86

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-594.23-609.44-745.68-331.73-297.69-145.84
Capital Expenditures
0.46--4.05-3.05-6.07-0.94
Free Cash Flow
-593.77-609.44-749.73-334.77-303.76-146.78
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.